October 2003
Worldwide Biotech;Oct2003, Vol. 15 Issue 10, p2
Trade Publication
Reports that 454 Life Sciences has obtained an exclusive license for sole use of sequencing by synthesis and pyrophosphate based sequencing for whole genome applications from Pyrosequencing AB as of October 2003.


Related Articles

  • New DNA Mapping Technology Enables Individualized Sequence Analysis. Holland-Moritz, Pam // Genomics & Proteomics;Oct2003, Vol. 3 Issue 8, p13 

    Focuses on the applications of the DNA sequencing by synthesis technology. Reduction of costs in obtaining genetic information; Completion of the whole-genome sequence of an adenovirus by 454 Life Sciences; Addition of reagents to create reactions that emit chemoluminescence; Use of slides...

  • Sequencers step up to the speed challenge. Dalton, Rex // Nature;9/21/2006, Vol. 443 Issue 7109, p258 

    The article reports on the availability of a tabletop DNA-sequencing machine for faster DNA sequences. The rapid analysis of a patient's genetic mutations is the expected market for the technology. A comparison of the techniques used by 454 Life Sciences and Applied Biosystems is presented. 454...

  • FROM SANGER TO 'SEQUENATOR' Strattner, Tony // Bio-IT World;Oct2003, Vol. 2 Issue 10, p1 

    Reports on the launch of an integrated platform that miniaturizes the basic steps of DNA sequencing, developed by the company 454 Life Sciences in Brandford, Connecticut in 2003. Information on the microfluidic technique that is used to prepare the DNA fragments for amplification; Significance...

  • Genome Center in a Box. Boguslavsky, Julia // Bio-IT World;Nov2003, Vol. 2 Issue 11, p64 

    Features the whole-genome analysis system, which utilizes an integrated end-to-end instrument that can perform various reactions in parallel, developed by biotechnology company 454 Life Sciences. Use of nanotechnology in the development of the system; Overview of the process of the system; Plan...

  • Fantastic 454: Sequencing Pyrotechnics. Davies, Kevin // Bio-IT World;Sep2005, Vol. 4 Issue 9, p1 

    Focuses on 454 Life Science Corp., a company investing into a nanoscale DNA sequencing platform founded by Jonathan Rothberg in the U.S. Utilization of a sequencing by synthesis approach to generate bases of bacterial genome data; Overview of the sequencing by synthesis approach; Efforts of...

  • Genomics: The personal side of genomics. Blow, Nathan // Nature;10/4/2007, Vol. 449 Issue 7162, p627 

    The article presents information on personal genomics, which is driven by DNA sequencing. It reports that different kinds of DNA-sequencing systems have been launched into the field of genetic-analysis. It informs that five companies are preparing to offer or are offering sequencers that are...

  • Agreements/contracts.  // Medical Device Daily;11/2/2010, Vol. 14 Issue 213, p4 

    The article reports on the exclusive partnership formed by 454 Life Sciences with DNA Electronics for the development of a DNA sequencing system.

  • Agreements/contracts.  // Medical Device Daily;10/20/2010, Vol. 14 Issue 204, p3 

    This article reports on the worldwide co-promotional agreement signed between 454 Life Sciences and Fluidigm for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.

  • Q & A: Marc Hodosh. Bjorn, Genevive // Nature Medicine;Jan2008, Vol. 14 Issue 1, p8 

    The article presents an interview with Marc Hodosh, senior director of the Archon X Prize for Genomics. When asked about the contest, he discloses that it is intended for companies that can engage with speedy gene mapping by accurately sequencing 100 human genomes at a maximum cost of $10,000...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics